TNG.PA PAR
Transgene S.A.
1W: -7.9%
1M: -20.9%
3M: -9.3%
YTD: -16.9%
1Y: -38.6%
3Y: -59.5%
5Y: -72.8%
€0.70 ($0.79)
-0.01 (-1.96%)
Weekly Expected Move ±4.8%
€1
€1
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$37M
-56.0% ▼
Capital Expenditures
$842K
+72.5% ▲
5Y CAGR: -0.2%
Free Cash Flow
-$38M
-41.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$10M
-1097.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$20M | -$33M | -$22M | -$34M | -$38M |
| Depreciation & Amort. | $3M | $2M | $2M | $1M | $1M |
| Stock-Based Comp. | $5M | $3M | $290K | $568K | $0 |
| Change in Working Capital | -$13M | $5M | -$7M | $11M | -$5M |
| Other Non-Cash Items | -$4M | $3M | -$7M | -$2M | $4M |
| Operating Cash Flow | -$32M | -$20M | -$35M | -$24M | -$37M |
| — Investing Activities — | |||||
| Capital Expenditures | -$686K | -$2M | -$3M | -$3M | -$842K |
| Acquisitions (Net) | $17M | $0 | $14M | $0 | $0 |
| Investment Purchases | -$40M | $0 | $0 | $0 | -$105M |
| Investment Sales | $17M | $22M | $23M | $0 | $0 |
| Other Investing | $23M | $22M | $332K | -$131K | -$109K |
| Investing Cash Flow | $17M | $20M | $35M | -$3M | -$106M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$197K | $0 | $13M | $29M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$2M | -$1M | -$1M | -$2M | $30M |
| Financing Cash Flow | $16M | -$1M | $11M | $27M | $134M |
| Net Change in Cash | $634K | -$2M | $11M | $1M | -$10M |
| Cash End of Period | $6M | $4M | $16M | $17M | $7M |
| Free Cash Flow | -$33M | -$22M | -$37M | -$27M | -$38M |